← Back to Search

Talking about Cancer (TAC) for Cancer

N/A
Waitlist Available
Led By Megan J Shen, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, follow-up (3 months)
Awards & highlights

Study Summary

This study is evaluating whether a communication-based intervention may help improve prognostic understanding for individuals with advanced cancer.

Eligible Conditions
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, follow-up (3 months)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, follow-up (3 months) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Prognostic Understanding
Secondary outcome measures
Change in Caregiver Burden (Caregivers Only), as Measured by the Zarit Burden Interview
Change in Caregivers' Engagement in Advance Care Planning, as Measured by the Van Scoy and Sudore Measure Which Adapts the Decision Maker Subscale of the Advance Care Planning Engagement Survey, From Baseline to 3-month Follow-up
Change in Caregivers' Engagement in Advance Care Planning, as Measured by the Van Scoy and Sudore Measure Which Adapts the Decision Maker Subscale of the Advance Care Planning Engagement Survey, From Baseline to Post-Intervention
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Patient intervention armExperimental Treatment1 Intervention
This intervention arm contains the patients from this single arm study in which patients and caregivers will be given the experimental intervention (TAC intervention) with assessments pre and post intervention. The intervention will consist of six 45-minute telephone-delivered sessions. Session topics will include: (a) Distress management/tolerance (Sessions 1 and 2); (b) communication skills (Sessions 3 and 4); (c) guided review of prognostic information (Session 5); and (d) Intervention review and future plan (Session 6). Sessions will be completed by the individual (Sessions 1 and 3) and dyad (Sessions 2, and 4-6).
Group II: Caregiver (of patient) intervention armExperimental Treatment1 Intervention
This intervention arm contains the caregivers of patients from this single arm study in which patients and caregivers will be given the experimental intervention (TAC intervention) with assessments pre and post intervention. The intervention will consist of six 45-minute telephone-delivered sessions. Session topics will include: (a) Distress management/tolerance (Sessions 1 and 2); (b) communication skills (Sessions 3 and 4); (c) guided review of prognostic information (Session 5); and (d) Intervention review and future plan (Session 6). Sessions will be completed by the individual (Sessions 1 and 3) and dyad (Sessions 2, and 4-6).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Talking about Cancer (TAC)
2020
N/A
~30

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,054 Previous Clinical Trials
1,316,500 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,657 Previous Clinical Trials
40,933,639 Total Patients Enrolled
Megan J Shen, PhDPrincipal InvestigatorFred Hutchinson Cancer Center
2 Previous Clinical Trials
450 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Patient-caregiver Communication Intervention for Prognostic Understanding
2020. "Patient-caregiver Communication Intervention for Prognostic Understanding". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03833817.
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top